Pediatr Infect Dis J. 2008 Jul;27(7):658-60.

Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.

Trofa AF, Levin M, Marchant CD, Hedrick J, Blatter MM.

Department of Clinical Research, Development, and Medical Affairs, Vaccines for Viral Diseases, GlaxoSmithKline, King of Prussia, PA 19406, USA.

The immunogenicity and safety of hepatitis A vaccine and pneumococcal conjugate vaccine, administered separately or concomitantly in children 15 months of age, were evaluated. After completed vaccinations, antihepatitis A and antipneumococcal geometric mean concentrations were similar across groups. Both vaccines were well-tolerated when given concomitantly during the second year of life.

PMID: 18536623 [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources:

Libraries:

LinkOut Holdings

Supplemental Content

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.
JAMA. 2005 Apr 13; 293(14):1751-8.

[JAMA. 2005]
Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age.
Pediatr Infect Dis J. 2005 Feb; 24(2):108-14.

[Pediatr Infect Dis J. 2005]
Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
Pediatr Infect Dis J. 2006 Oct; 25(10):912-9.

[Pediatr Infect Dis J. 2006]
ReviewRoutine vaccines across the life span, 2005.
J Fam Pract. 2005 Jan; 54(1 Suppl):S9-26.

[J Fam Pract. 2005]
Review[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]
Ned Tijdschr Geneeskd. 2007 Jun 30; 151(26):1454-7.

[Ned Tijdschr Geneeskd. 2007]
» See reviews... | » See all...

Patient drug information

Pneumococcal Polysaccharide Vaccine (Pneumovax® 23)
Pneumococcal disease is caused byStreptococcus pneumoniae bacteria. It is a leading cause of vaccine-preventable illness and death in the United States. Anyone can get pneumococcal disease, but some people are at greater...
Meningococcal Vaccine (Menomune®, Menactra®)
Meningococcal disease is a serious bacterial illness. It is a leading cause of bacterial meningitis in children 2 through 18 years old in the United States.
Pneumococcal Conjugate Vaccine (Prevnar®)
Infection withStreptococcus pneumoniae bacteria can cause serious illness and death. Invasive pneumococcal disease is responsible for about 200 deaths each year among children under 5 years old. It is the leading cause o...
» See all 4 drug reports ...
Source: AHFS Consumer Medication Information

All links from this record

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly...Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sc...Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.
Can methylphenidate reduce fall risk in community-living older adults? A double-blind, sin...Can methylphenidate reduce fall risk in community-living older adults? A double-blind, single-dose cross-over study.
Pneumococcal vaccination in nursing homes: does race make a difference?Pneumococcal vaccination in nursing homes: does race make a difference?
Coruzzi[Author] AND (("pl...Coruzzi[Author] AND (("plants"[MeSH Terms] OR "plants"[All Fields]) OR ("yeasts"[MeSH Terms] OR "yeasts"[All Fields] OR "yeast"[All Fields] OR "yeast, dried"[MeSH Terms] OR ("yeast"[All Fields] AND "dried"[All Fields]) OR "dried yeast"[All Fields] OR "yeast"[All Fields] OR "saccharomyces cerevisiae"[MeSH Terms] OR ("saccharomyces"[All Fields] AND "cerevisiae"[All Fields]) OR "saccharomyces cerevisiae"[All Fields]) OR ("informatics"[MeSH Terms] OR "informatics"[All Fields]) OR ("genomics"[MeSH Terms] OR "genomics"[All Fields]) OR ("arabidopsis"[MeSH Terms] OR "arabidopsis"[All Fields]))(74)

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

» See more...

PubMed

Display Settings:

Send to:

Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.

Publication Types, MeSH Terms, Substances

Publication Types:

MeSH Terms:

Substances:

LinkOut - more resources

Full Text Sources:

Libraries:

Supplemental Content

Related articles

Patient drug information

All links from this record

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information